Fact CheckerSign in

NCT07570056Not yet recruiting

Use of Electrical Bioimpedance in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients (Bioimpedance)

A Pilot Study for the Use of Electrical Bioimpedance in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients (Bioimpedance)

Source: ClinicalTrials.gov · Last updated 30 Sept 2026

Brief summary (registry, in English)

The goal of this project is to test non-invasive, painless skin electrical bioimpedance (BioZ) measurements as an adjunctive biomarker to standard bone marrow biopsies.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
25 (estimated)
First submitted
29 Apr 2026
Start date
1 Oct 2026
Primary completion date
31 Jul 2027
Lead sponsor
University of Utah
NCT number
NCT07570056

What you commit to

  • Study type: Observational
  • Planned participants: 25
  • From 1 Oct 2026 to the primary completion date, 31 Jul 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Study prospect that has an electronic implant (cardiac, neurological, sensory, prosthetic implants with an electronic component. Also monitoring and drug delivery systems.)
  • Medical, psychiatric, cognitive, or other conditions that may compromise the participant's ability to understand the participant information, give informed consent, comply with the study protocol or complete the study.

Other

  • Pregnant women
  • Inability to understand and/or speak the English or Spanish language.

Who the study is looking for

  • Suspected or confirmed diagnosis of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) and undergoing a bone marrow biopsy.
  • Age 18 or older.
  • Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.